Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

4.30
+0.600016.22%
Post-market: 4.300.00000.00%19:45 EDT
Volume:265.23K
Turnover:1.12M
Market Cap:24.89M
PE:1.99
High:4.35
Open:3.83
Low:3.83
Close:3.70
Loading ...
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

Major Issues Report

Form 8-K - Current report
Apr 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]